Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
Valentina Guarneri(Istituto Oncologico Veneto), PierFranco Conte(University of Padua), Fabrizio Artioli(Roche (Switzerland)), Roberto D’Amico(University of Modena and Reggio Emilia), Daniele Generali(University of Trieste), Alberto Bottini(University of Genoa), Samanta Sarti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Giardina(Istituti Ospitalieri di Cremona), C. Boni(Ospedale Santa Maria), Patrizia Serra(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giancarlo Bisagni, Antonino Musolino(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Luigi Cavanna(University of Pavia), Federico Piacentini(Azienda Unita' Sanitaria Locale Di Modena), Laura Orlando, Alberto Ravaioli(Florence (Netherlands)), Michael Untch(Helios Kliniken), Luca Marini, M. Bagnalasta(GlaxoSmithKline (Netherlands))
Cited by 368
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k